Samuel E Moses
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
- Modeling and Simulation top 1%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 17
- COVID-19 Clinical Research Studies 12
- SARS-CoV-2 detection and testing 6
- HIV/AIDS Research and Interventions 6
- Epidemiology 20
- Hepatitis B Virus Studies 9
- Liver Disease Diagnosis and Treatment 6
- Co-authors
- ELIZABETH N. NGUGI (2 shared papers)FA Plummer (1 shared paper)JO Ndinya–Achola (1 shared paper)Mark A. Zuckerman (4 shared papers)Peter Piot (2 shared papers)Isaac A Wamola (2 shared papers)Marleen Temmerman (3 shared papers)Malur Sudhanva (2 shared papers)
- Journals
- Nature (4 papers)Gut (4 papers)The Lancet Respiratory Medicine (3 papers)Scientific Reports (3 papers)Nature Communications (3 papers)
- Partner nations
- United KingdomUnited StatesKenya
In The Last Decade
Samuel E Moses
61 papers receiving 5.9k citations
Samuel E Moses's Hit Papers
Peers
Comparison fields: 5 of 144
- Infectious Diseases 4.2k
- Modeling and Simulation 404
- Animal Science and Zoology 501
- Neurology 558
- Immunology 511
Countries citing papers authored by Samuel E Moses
This map shows the geographic impact of Samuel E Moses's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel E Moses with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel E Moses more than expected).
Fields of papers citing papers by Samuel E Moses
This network shows the impact of papers produced by Samuel E Moses. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel E Moses. The network helps show where Samuel E Moses may publish in the future.
Co-authors
The 25 scholars most cited alongside Samuel E Moses, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses Hit paper breakdown → | 2022 | 740 |
| 2 | Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity Hit paper breakdown → | 2020 | 734 |
| 3 | SARS-CoV-2 evolution during treatment of chronic infection Hit paper breakdown → | 2021 | 698 |
| 4 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 641 |
| 5 | Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Hit paper breakdown → | 2021 | 524 |
| 6 | SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Hit paper breakdown → | 2022 | 457 |
| 7 | Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 Hit paper breakdown → | 2021 | 316 |
| 8 | 2021 | 224 | |
| 9 | 2021 | 161 | |
| 10 | 2021 | 160 | |
| 11 | 2021 | 135 | |
| 12 | 2021 | 119 | |
| 13 | The importance of core groups in the epidemiology and control of HIV-1 infection. | 1991 | 113 |
| 14 | 2022 | 86 | |
| 15 | 2021 | 75 | |
| 16 | 2021 | 68 | |
| 17 | 2021 | 67 | |
| 18 | Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease Hit paper breakdown → | 2024 | 65 |
| 19 | 1990 | 58 | |
| 20 | 2021 | 50 |
About Samuel E Moses
Samuel E Moses is a scholar working on Infectious Diseases, Epidemiology, Hepatology, Modeling and Simulation and Neurology, having authored 63 papers that have together received 6.0k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 Clinical Research Studies (12 papers), Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (7 papers), SARS-CoV-2 detection and testing (6 papers), HIV/AIDS Research and Interventions (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and COVID-19 epidemiological studies (5 papers). The work is most often cited by research in Infectious Diseases (4.2k citations), Modeling and Simulation (404 citations), Animal Science and Zoology (501 citations), Neurology (558 citations) and Immunology (511 citations). Samuel E Moses has collaborated with scholars based in United Kingdom, United States and Kenya. Frequent co-authors include ELIZABETH N. NGUGI, FA Plummer, JO Ndinya–Achola, Mark A. Zuckerman, Peter Piot, Isaac A Wamola, Marleen Temmerman, Malur Sudhanva, Zi Yi Lim and Francis Allan Plummer. Their work appears in journals such as Nature, Gut, The Lancet Respiratory Medicine, Scientific Reports and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.